CIK 0001521036
- Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 352318913
- Phone
- +1 978-671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- 4 Open-market sale Director sold 5,000 shares at $21.17 ($105,840)
- 4 Open-market buy Director bought 1,000 shares at $18.60 ($18,600)
- 4 Open-market sale President & CEO sold 27,157 shares at $18.26 ($495,838)
- 4 Grant or award President & CEO acquired 162,338 shares (grant or award)
- 4 Open-market sale Chief Commercial Officer sold 4,061 shares at $18.40 ($74,722)
- 4 Open-market sale Chief Operations Officer sold 1,887 shares at $18.40 ($34,721)
- 4 Open-market sale SVP and General Counsel sold 6,769 shares at an average $18.97 ($128,379)
- 4 Open-market sale CFO and Treasurer sold 2,280 shares at $18.40 ($41,952)
- 4 Open-market sale Chief Medical Officer sold 4,027 shares at $18.40 ($74,097)
- 4 Open-market sale SVP and General Counsel sold 1,473 shares at $19.08 ($28,108)
- 4 Open-market sale Chief Operations Officer sold 1,187 shares at $19.08 ($22,650)
- 4 Open-market sale CFO and Treasurer sold 1,465 shares at $19.08 ($27,955)
- 4 Open-market buy Director bought 1,000 shares at $18.02 ($18,020)
- 4 Open-market buy Director bought 1,000 shares at $19.39 ($19,390)
- 4 Open-market buy Director bought 1,000 shares at $20.03 ($20,030)
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Director bought 1,000 shares at $17.94 ($17,940)
- 4 Open-market buy Director bought 1,000 shares at $16.13 ($16,130)
- 4 Open-market buy Director bought 1,000 shares at $15.29 ($15,290)
- 4 Open-market buy Director bought 1,000 shares at $15.80 ($15,800)
Page 16 of 30 · 599 filings